Thermo Fisher Scientific and NCI launch myeloMATCH trial to advance AML and MDS treatment
In a significant advancement in cancer treatment, Thermo Fisher Scientific Inc. (NYSE: TMO) has partnered with the National Cancer Institute (NCI), a component of the ... Read More
Oxford BioDynamics collaborates with National Cancer Institute in prostate cancer clinical trial
Oxford BioDynamics Plc (AIM: OBD), a pioneering biotechnology company, has announced its participation in a significant clinical trial led by the National Cancer Institute (NCI) ... Read More
Infosys opens rest house at National Cancer Institute in AIIMS, Jhajjar
Infosys said that its philanthropic and CSR arm — Infosys Foundation inaugurated the ‘Infosys Foundation Vishram Sadan’, a rest house near the National Cancer Institute ... Read More